Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Smithkline Beecham Pharmaceuticals (Pty) Ltd, a prominent player in the pharmaceutical industry, is headquartered in South Africa (ZA) and operates extensively across the African continent. Founded in the late 20th century, the company has established itself as a leader in the development and distribution of innovative healthcare solutions.
Specialising in prescription medications, vaccines, and consumer health products, Smithkline Beecham is renowned for its commitment to research and development, which drives the creation of unique therapies tailored to meet diverse health needs. The company has achieved significant milestones, including strategic partnerships and a robust portfolio of core products that address critical health challenges.
With a strong market position, Smithkline Beecham Pharmaceuticals continues to make notable contributions to public health, reinforcing its reputation as a trusted name in the pharmaceutical sector.
+66 vs industry average
Smithkline Beecham Pharmaceuticals (Pty) Ltd’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Apparel Production has below-average carbon intensity
The Apparel Production industry has reduced its overall emissions by 24% since 2018
No reported emissions data is available for Smithkline Beecham Pharmaceuticals (Pty) Ltd yet.
Smithkline Beecham Pharmaceuticals (Pty) Ltd, headquartered in South Africa (ZA), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of GSK plc, and as such, it inherits its climate commitments and initiatives from its parent organisation.
GSK plc has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which cascade down to Smithkline Beecham Pharmaceuticals (Pty) Ltd at a cascade level of 4. However, specific reduction targets or achievements for Smithkline Beecham Pharmaceuticals (Pty) Ltd are not detailed in the available data.
As part of its commitment to sustainability, GSK plc has made significant strides in addressing climate change, which reflects on its subsidiaries. The company is actively working towards reducing its carbon footprint and enhancing its environmental performance, although specific metrics for Smithkline Beecham Pharmaceuticals (Pty) Ltd are not provided.
In summary, while Smithkline Beecham Pharmaceuticals (Pty) Ltd does not have specific emissions data or reduction targets available, it is aligned with the broader climate commitments of GSK plc, focusing on sustainability and carbon reduction initiatives.
No climate goals have been disclosed for Smithkline Beecham Pharmaceuticals (Pty) Ltd yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Smithkline Beecham Pharmaceuticals (Pty) Ltd yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more